Skip to content

Sequential Method Determination of Oxycodone for Thoracoscope Surgery Median Effective Dose of Acute Pain Treatment

Sequential Method Determination of Oxycodone for Thoracoscope Surgery Median Effective Dose of Acute Pain Treatment

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06534801
Enrollment
60
Registered
2024-08-02
Start date
2024-09-01
Completion date
2026-04-01
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Postoperative Pain, Oxycodone, Thoracoscopic Lobectomy

Brief summary

The goal of this clinical trial is to measure the median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy. This clinical trial was divided into two groups based on age, Group I (Age \< 65 years old) and Group II (Age ≥65 years old). We used the sequential allocation designed by Dixon. The initial oxycodone dose was set to 0.1 mg/kg.A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point was included as the first case for ED50 estimation in each group.The study was conducted until 7 crossover points were collected

Interventions

DRUGOxycodone will be administered intravenously in the group 1

Oxycodone will be administered intravenously 30min before the end of surgery, and Dixon sequential method will be used for the study

Sponsors

Jianbo Wu
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. The first unilateral thoracoscopic lobectomy was performed under general anesthesia 2. age 18- 80 years old 3. American Society of Anesthesiologists (ASA) physical status I-III 4. Sign the informed consent of the patients

Exclusion criteria

1. Moderate to severe obesity (i.e., BMI \> 30kg/m2) 2. Allergic or hypersensitive reaction to oxycodon 3. A history of chronic pain 4. Patients with significant heart, pulmonary, liver or renal disease

Design outcomes

Primary

MeasureTime frameDescription
The median effective dose3 minutes after remoal of the endotracheal tube, 30minutes after remoal of the endotracheal tubeThe median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy

Contacts

Primary ContactWu Jian bo, doctorate
jianbowu@126.com18560083793
Backup ContactZhang min, master
ZM18364183909@163.com18364183909

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026